Ameritas Investment Partners’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-498
Closed -$16K 3056
2022
Q2
$16K Hold
498
﹤0.01% 2672
2022
Q1
$17K Buy
498
+1
+0.2% +$33 ﹤0.01% 2636
2021
Q4
$17K Buy
+497
New +$17.4K ﹤0.01% 2729

Ameritas Investment Partners's IEIH Position: Q3 2022 in Review

Ameritas Investment Partners sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 498 shares — an estimated $16K sold.

Ameritas Investment Partners first reported a position in IEIH in Q4 2021 and held it in 3 quarters. The position peaked at $17K in Q1 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • Ameritas Investment Partners reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 498 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $16K.
  • Ameritas Investment Partners first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q4 2021 and held it in 3 quarters.
  • Ameritas Investment Partners's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $17K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Ameritas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.